Use of personal protective equipment while admixing antineoplastic drugs during the COVID-19 pandemic era: Questionnaire survey in Niigata, Japan

J Oncol Pharm Pract. 2020 Sep;26(6):1553-1554. doi: 10.1177/1078155220932342. Epub 2020 May 29.

Authors

Satoru Mitsuboshi¹, Masaki Yoshino², Hiroki Hosokawa³, Hirokazu Isobe⁴, Kenichi Kobayashi⁵

Affiliations

¹ Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
² Departments of Pharmacy, Niigata Prefectural Cancer Center Hospital, Niigata, Japan.
³ Department of Pharmacy, Agano City Hospital, Niigata, Japan.
⁴ Division of Pharmacy, Niigata University Medical and Dental Hospital, Niigata, Japan.
⁵ Department of Pharmacy, Nagaoka Red Cross Hospital, Niigata, Japan.

PMID: 32469683
DOI: 10.1177/1078155220932342

No abstract available

Publication types

Letter
Comment

MeSH terms

Antineoplastic Agents*
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Japan
Pandemics*
Personal Protective Equipment*
Pneumonia, Viral*
SARS-CoV-2
Surveys and Questionnaires

Substances

Antineoplastic Agents